UPDATE: Goldman Sachs Starts Signify Health Inc (SGFY) at Neutral

March 8, 2021 3:19 AM EST
Get Alerts SGFY Hot Sheet
Price: $26.26 +0.61%

Rating Summary:
    4 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 8 | New: 31
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - March 8, 2021 4:15 AM EST)

Goldman Sachs analyst Robert Jones initiates coverage on Signify Health Inc (NYSE: SGFY) with a Neutral rating and a price target of $31.00.

The analyst comments "We initiate coverage on Signify Health (SGFY) with a Neutral rating and 12-month price target of $31. In our view, SGFY is a unique HC tech-enabled-services asset, growing at over 20% at healthy EBITDA margins (20%+). We like the company’s exposure to Medicare Advantage (75% of revenues – for context on why we see the MA end-market as attractive see HERE) and somewhat diversified client base across payors (75% of revenues) and providers (25%). Though the company has a clear path to growth outlined in this note, with shares trading at 9.5x our NTM EV/Sales we initiate at Neutral as the risk/reward is more balanced from here."

For an analyst ratings summary and ratings history on Signify Health Inc click here. For more ratings news on Signify Health Inc click here.

Shares of Signify Health Inc closed at $28.31 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, New Coverage

Related Entities

Goldman Sachs